Es gab 50 kürzliche Insider-Transaktionen für Omega Therapeutics, Inc. (OMGA), darunter 35 Käufe und 6 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $17.43M und die gesamten Insider-Verkäufe auf $855.29K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Varsalone Jeffrey T, Mehrotra Ravi, Nelson Jennifer Ann. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — OMGA
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-01-24 |
Varsalone Jeffrey T |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-12-03 |
Mehrotra Ravi |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-12-03 |
Mehrotra Ravi |
Director |
RSU-Zuteilung |
50,000 |
$0.95 |
$47.45K |
50,000 |
| 2024-11-22 |
Nelson Jennifer Ann |
Chief Scientific Officer |
Unbekannt |
110,000 |
$1.47 |
$161.7K |
- |
| 2024-11-22 |
Nelson Jennifer Ann |
Chief Scientific Officer |
RSU-Zuteilung |
110,000 |
$0.79 |
$86.46K |
110,000 |
| 2024-11-15 |
Certel Kaan |
See Remarks |
RSU-Zuteilung |
340,000 |
$0.83 |
$281.66K |
340,000 |
| 2024-10-02 |
Rosiello Robert L. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-10-02 |
Rosiello Robert L. |
Director |
RSU-Zuteilung |
50,000 |
$1.09 |
$54.5K |
50,000 |
| 2024-06-20 |
Schade Christian S |
Director |
RSU-Zuteilung |
25,000 |
$2.20 |
$55K |
25,000 |
| 2024-06-20 |
Mendlein John |
Director |
RSU-Zuteilung |
25,000 |
$2.20 |
$55K |
25,000 |
| 2024-06-20 |
Kender Richard N |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-06-20 |
Kender Richard N |
Director |
RSU-Zuteilung |
50,000 |
$2.20 |
$110K |
50,000 |
| 2024-06-20 |
Szela Mary T |
Director |
RSU-Zuteilung |
25,000 |
$2.20 |
$55K |
25,000 |
| 2024-06-20 |
Young Richard A |
Director |
RSU-Zuteilung |
25,000 |
$2.20 |
$55K |
25,000 |
| 2024-06-20 |
Boehm Rainer J. |
Director |
RSU-Zuteilung |
25,000 |
$2.20 |
$55K |
25,000 |
| 2024-06-20 |
Levy Elliott M. |
Director |
RSU-Zuteilung |
25,000 |
$2.20 |
$55K |
25,000 |
| 2024-06-20 |
Werner Michelle C |
Director |
RSU-Zuteilung |
25,000 |
$2.20 |
$55K |
25,000 |
| 2024-05-31 |
Chan Barbara Y |
Chief Accounting Officer |
Veräußerung |
87,352 |
$5.67 |
$495.29K |
- |
| 2024-05-31 |
Certel Kaan |
Chief Business Officer |
RSU-Zuteilung |
220,000 |
$1.98 |
$435.6K |
220,000 |
| 2024-05-28 |
Certel Kaan |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-02-07 |
Schade Christian S |
Director |
RSU-Zuteilung |
512,848 |
$3.59 |
$1.84M |
512,848 |
| 2024-02-07 |
Reed Joshua |
Chief Financial Officer |
RSU-Zuteilung |
110,000 |
$3.59 |
$394.9K |
110,000 |
| 2024-02-07 |
Zeng Ling |
See Remarks |
RSU-Zuteilung |
125,000 |
$3.59 |
$448.75K |
125,000 |
| 2024-02-07 |
Mccauley Thomas |
Chief Scientific Officer |
RSU-Zuteilung |
75,000 |
$3.59 |
$269.25K |
75,000 |
| 2024-02-07 |
Karande Mahesh |
President and CEO |
RSU-Zuteilung |
209,551 |
$3.59 |
$752.29K |
209,551 |
| 2024-02-07 |
Moore Yan |
Chief Medical Officer |
RSU-Zuteilung |
110,000 |
$3.59 |
$394.9K |
110,000 |
| 2023-08-28 |
Werner Michelle C |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-08-28 |
Werner Michelle C |
Director |
RSU-Zuteilung |
36,713 |
$3.62 |
$132.9K |
36,713 |
| 2023-07-10 |
Schade Christian S |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-07-10 |
Schade Christian S |
Director |
RSU-Zuteilung |
36,713 |
$4.69 |
$172.18K |
36,713 |
| 2023-06-07 |
Beshar Luke M |
Director |
RSU-Zuteilung |
18,118 |
$8.39 |
$152.01K |
18,118 |
| 2023-06-07 |
Afeyan Noubar |
10 Percent Owner |
RSU-Zuteilung |
18,118 |
$8.39 |
$152.01K |
18,118 |
| 2023-06-07 |
Mendlein John |
Director |
RSU-Zuteilung |
18,118 |
$8.39 |
$152.01K |
18,118 |
| 2023-06-07 |
Szela Mary T |
Director |
RSU-Zuteilung |
18,118 |
$8.39 |
$152.01K |
18,118 |
| 2023-06-07 |
Young Richard A |
Director |
RSU-Zuteilung |
18,118 |
$8.39 |
$152.01K |
18,118 |
| 2023-06-07 |
Boehm Rainer J. |
Director |
RSU-Zuteilung |
18,118 |
$8.39 |
$152.01K |
18,118 |
| 2023-06-07 |
Levy Elliott M. |
Director |
RSU-Zuteilung |
18,118 |
$8.39 |
$152.01K |
18,118 |
| 2023-06-02 |
Young Richard A |
Director |
Informierter Verkauf |
5,000 |
$8.00 |
$40K |
739,118 |
| 2023-05-01 |
Young Richard A |
Director |
Informierter Verkauf |
5,000 |
$8.00 |
$40K |
744,118 |
| 2023-04-06 |
Young Richard A |
Director |
Informierter Verkauf |
5,000 |
$8.00 |
$40K |
749,118 |
| 2023-03-17 |
Young Richard A |
Director |
Informierter Verkauf |
10,000 |
$8.00 |
$80K |
754,118 |
| 2023-02-28 |
Reed Joshua |
Chief Financial Officer |
RSU-Zuteilung |
55,000 |
$6.46 |
$355.3K |
55,000 |
| 2023-02-28 |
Zeng Ling |
See Remarks |
RSU-Zuteilung |
55,000 |
$6.46 |
$355.3K |
55,000 |
| 2023-02-28 |
Mccauley Thomas |
Chief Scientific Officer |
RSU-Zuteilung |
55,000 |
$6.46 |
$355.3K |
55,000 |
| 2023-02-28 |
Karande Mahesh |
President and CEO |
RSU-Zuteilung |
170,000 |
$6.46 |
$1.1M |
170,000 |
| 2023-02-28 |
Moore Yan |
Chief Medical Officer |
RSU-Zuteilung |
55,000 |
$6.46 |
$355.3K |
55,000 |
| 2023-02-28 |
Mcmanus Kevin |
Chief Human Resources Officer |
RSU-Zuteilung |
55,000 |
$6.46 |
$355.3K |
55,000 |
| 2023-02-27 |
Flagship Pioneering Inc. |
10 Percent Owner |
Informierter Kauf |
1,329,324 |
$5.78 |
$7.68M |
1,329,324 |
| 2023-02-27 |
Flagship Pioneering Fund Vii General Partner Llc |
10 Percent Owner |
Unbekannt |
- |
- |
- |
1,329,324 |
| 2023-01-10 |
Young Richard A |
Director |
Informierter Verkauf |
20,000 |
$8.00 |
$160K |
764,118 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
